playtoearncryptogamesfree| Kelun Pharmaceutical (002422.SZ) plans to subscribe for domestic shares issued by its holding subsidiary Kelun Botai with a subscription amount of 603 million yuan

Glonghui May 8 丨 Kelun Pharmaceutical (002422)(002422playtoearncryptogamesfree.SZ) announcedplaytoearncryptogamesfree, in order to further promote the companyplaytoearncryptogamesfreeTo ensure the orderly development of its holding subsidiary Sichuan Kolenotai Biomedical Co., Ltd.("Kolenotai"), maintain the stability of Kolenotai's equity structure, and enhance Kolenotai's competitiveness, Kolenotai plans to issue domestic shares to the company while issuing H shares on the Hong Kong Stock Exchange. The company plans to subscribe for all the domestic shares it will issue. The two parties signed the "Subscription Agreement for Targeted Issuance of Shares" on May 8, 2024. The subscription price of this time is determined based on the price of H shares issued by Colenotek on the Hong Kong Stock Exchange after taking into account exchange rate factors, which is RMB 136.21/share. The subscription quantity is 4playtoearncryptogamesfree, 423,870 shares, with a subscription amount of RMB 602,575,332.70. After the completion of this subscription, the company and its wholly-owned subsidiary Kelun International Development Co., Ltd.(hereinafter referred to as "Kelun International") will directly hold approximately 54.80% of the shares of Kelun Botai, and the company will remain the controlling shareholder of Kelun Botai.

Tags:

Prev: pennslammeriiispinningreel6500| Intensive name changes, and nearly 50 companies have been "wearing stars and hats" a day!
Next: freespingames| The equity reorganization of Peking University Resources took effect: new shares opened on May 8, and the lot number was adjusted to 8000 shares